pharmacokinetics

(redirected from pharmacokinetic)
Also found in: Thesaurus, Medical, Encyclopedia.

phar·ma·co·ki·net·ics

 (fär′mə-kō-kə-nĕt′ĭks, -kī-)
n. (used with a sing. verb)
1. The process by which a drug is absorbed, distributed, metabolized, and eliminated by the body.
2. The study of this process.

phar′ma·co·ki·net′ic adj.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

pharmacokinetics

(ˌfɑːməkəʊkɪˈnɛtɪks; -kaɪ-)
n
(Pharmacology) the branch of pharmacology concerned with the way drugs are taken into, move around, and are eliminated from, the body
ˌpharmacokiˈnetic adj
ˌpharmacokiˈnetically adv
pharmacokineticist n
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

phar•ma•co•ki•net•ics

(ˌfɑr mə koʊ kɪˈnɛt ɪks, -kaɪ-)

n.
(used with a pl. v.) the actions of drugs within the body, as their absorption, distribution, metabolism, and elimination.
[1955–60]
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.pharmacokinetics - the study of the action of drugs in the body: method and rate of excretion; duration of effect; etc.
materia medica, pharmacological medicine, pharmacology - the science or study of drugs: their preparation and properties and uses and effects
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Translations

phar·ma·co·ki·net·ics

n. farmacocinética, estudio in vivo del metabolismo y acción de las drogas.
English-Spanish Medical Dictionary © Farlex 2012
References in periodicals archive ?
Determination of oral meloxicam pharmacokinetic parameter in Asian Indian comparison with German population.
Like other pharmacokinetic parameters, clearance displays some inter- and intraindividual variation, but other than a circadian rhythm, it does not change systematically with time over the 4 days of administration.
ABSTRACT: The pharmacokinetic parameters of ciprofloxacin were determined following oral administration of a single dose of 20mg/kg body weight in normal rabbits and these changes were observed in experimentally induced diabetic rabbits.
Pharmacokinetic and pharmacodynamic interactions of echinacea and policonsanol with warfarin in healthy subjects.
The studies included two phase III trials: one investigating linagliptin monotherapy in type 2 diabetes patients for whom metformin therapy is inappropriate,1 and the other studying linagliptin as add-on therapy to a sulphonylurea in patients with inadequately controlled type 2 diabetes.2 In addition, a pharmacokinetic study was presented at the congress which investigated linagliptin in a special patient population with different degrees of renal impairment.3
Based on top line data, the trial achieved the primary endpoint demonstrating pharmacokinetic bioequivalence between CE-Iohexol injection and a reference Iohexol injection, or Omnipaque, after intravenous, or IV, administration in healthy adults.
- The first patient has been dosed in a Phase 1 clinical study that will examine pharmacokinetic properties of nalmefene hydrochloride, US-based Purdue Pharma L.P.'s said.
The agency added that the use of Ruzurgi in patients six to less than 17 years of age is supported on evidence based on the adequate and well-controlled studies of the drug in adults with LEMS, pharmacokinetic data in adult patients, pharmacokinetic modeling and simulation to identify the dosing regimen in paediatric patients as well as the safety data from paediatric patients.
Simcyp is a provider of mechanistic modeling technologies used to inform drug development, including physiologically based pharmacokinetic (PBPK), quantitative systems pharmacology (QSP) and quantitative systems toxicology and safety (QSTS) approaches.
This study (OAS-04-01) was a tolerance and pharmacokinetic study where the dose for Apealea (paclitaxel micellar) was determined.